Table 1 OCT4 expression in cervical cancer patients with different status
From: OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway
Groups | n | OCT4 IRS (
| t | P a |
---|---|---|---|---|
Primary site without HPV | 8 | 9.00±1.55 | ||
Primary site with HPV | 36 | 11.00±0.69 | 1.22 | 0.23 |
Primary site without lymphatic metastasis | 32 | 9.59±0.77 | ||
Primary site with lymphatic metastasis | 12 | 13.42±0.60 | 2.91 | 0.0058 |